Results 41 to 50 of about 1,148,410 (327)

COVID-19 and Equitable Distribution of Vaccine: Emerging Debates within the Framework of the World Trade Organization Agreements

open access: yesPublic and Private International Law Bulletin, 2021
Vaccine nationalism is an obstacle to combating the global COVID-19 pandemic. Since the production of COVID-19 vaccines is still insufficient to meet the needs of the world population, developed countries primarily purchase them for their populations ...
Meltem Sarıbeyoğlu Skalar
doaj   +1 more source

Novel Genetic Risk Factor Identified for L‐Asparaginase‐Induced Pancreatitis in Pediatric Patients With Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background L‐asparaginase is a critical component in treatment protocols for pediatric acute lymphoblastic leukemia. Acute pancreatitis reactions can necessitate delays and, in some cases, discontinuation of L‐asparaginase, which compromises outcomes.
Edward J. Raack   +39 more
wiley   +1 more source

Patents and licensing in pharmaceutical industry [PDF]

open access: yesMakedonsko Farmacevtski Bilten, 2005
Intellectual property rights (IPR) have been defined as ideas, inventions, and creative expressions based on which there is a public willingness to bestow the status of property.
Katerina Ancevska Netkovska   +3 more
doaj  

Brexit – The Consequences for Pharmaceutical Patents and Supplementary Protection Certificates

open access: yesBritish Journal of Pharmacy, 2021
Now that the UK has left the EU, and the transition period following this departure is over, we have a clearer view on the implications of Brexit on intellectual property rights and the consequences for UK based pharmaceutical companies. Although little
Harry Melville O'Brien   +2 more
doaj   +1 more source

The Value of Failures in Pharmaceutical R&D [PDF]

open access: yes, 2012
We build a cumulative innovation model in which both success and failure provide valuable information for future research. To test this learning mechanism, we use a dataset covering outcomes of world-wide R&D projects in the pharmaceutical industry, and ...
Chiou, Jing-Yuan   +3 more
core  

Upacicalcet: A Novel Intravenous Calcimimetic Agent for Patients Undergoing Hemodialysis With Secondary Hyperparathyroidism

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Secondary hyperparathyroidism (SHPT) is a common complication in patients receiving maintenance dialysis, driven by calcium and phosphate metabolism disturbances. Calcimimetics are central to the management of SHPT by enhancing calcium‐sensing receptor sensitivity and reducing parathyroid hormone secretion.
Fumihiko Koiwa   +3 more
wiley   +1 more source

Case Law: A Review of Selected Pharmaceutical Patents in the UK Courts during 2021

open access: yesBritish Journal of Pharmacy, 2022
Patents lie at the interface between technology and law. This review provides a summary of four high-profile cases from 2021 in which patents in the pharmaceutical or medical space were litigated in the UK Courts.
Sarah-Jane Crawford   +2 more
doaj   +1 more source

Pharmaceutical Patents in Developing Nations: Parallel Importation and the Doctrine of Exhaustion

open access: yes, 2014
This article examines the impact of parallel importation and the doctrine of patent exhaustion on access to pharmaceutical products in developing nations around the world. Parallel importation is of particular relevance to developing countries given that
Sarah McKeith
semanticscholar   +1 more source

Function‐driven design of a surrogate interleukin‐2 receptor ligand

open access: yesFEBS Letters, EarlyView.
Interleukin (IL)‐2 signaling can be achieved and precisely fine‐tuned through the affinity, distance, and orientation of the heterodimeric receptors with their ligands. We designed a biased IL‐2 surrogate ligand that selectively promotes effector T and natural killer cell activation and differentiation. Interleukin (IL) receptors play a pivotal role in
Ziwei Tang   +9 more
wiley   +1 more source

Organ‐specific redox imbalances in spinal muscular atrophy mice are partially rescued by SMN antisense oligonucleotides

open access: yesFEBS Letters, EarlyView.
We identified a systemic, progressive loss of protein S‐glutathionylation—detected by nonreducing western blotting—alongside dysregulation of glutathione‐cycle enzymes in both neuronal and peripheral tissues of Taiwanese SMA mice. These alterations were partially rescued by SMN antisense oligonucleotide therapy, revealing persistent redox imbalance as ...
Sofia Vrettou, Brunhilde Wirth
wiley   +1 more source

Home - About - Disclaimer - Privacy